Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.


In continuation of our efforts toward the discovery of potent non-nucleoside hepatitis B virus (HBV) inhibitors with novel structures, we have employed bioisosterism and hybrid pharmacophore-based strategy to explore the chemically diverse space of bioactive compounds. In this article, the original thiazole platform was replaced with pyrazole scaffold to… (More)
DOI: 10.1016/j.ejmech.2016.07.048


6 Figures and Tables

Slides referencing similar topics